+关注
SamuChong
暂无个人介绍
IP属地:未知
4
关注
1
粉丝
0
主题
0
勋章
主贴
热门
SamuChong
2021-12-02
[Surprised]
Wall St turns red as Omicron reaches the United States
SamuChong
2021-12-06
Board risk off sentiments now - Expect higher volatility till the end of the year.
@经济观察报:EEO全球财经周报 | 奥密克戎已散播至美国15个州;日本拟不再允许留学生免税购物;半导体市场规模2022年预计突破6000亿美元
SamuChong
2021-11-30
[微笑]
DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
SamuChong
2021-11-25
good read
Cathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578464057789843","uuid":"3578464057789843","gmtCreate":1637759598477,"gmtModify":1637759598477,"name":"SamuChong","pinyin":"samuchong","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.21","exceedPercentage":"80.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.26","exceedPercentage":"93.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.05.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":606054517,"gmtCreate":1638802922540,"gmtModify":1638802922637,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"Board risk off sentiments now - Expect higher volatility till the end of the year.","listText":"Board risk off sentiments now - Expect higher volatility till the end of the year.","text":"Board risk off sentiments now - Expect higher volatility till the end of the year.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606054517","repostId":"608423292","repostType":1,"repost":{"id":608423292,"gmtCreate":1638781335000,"gmtModify":1638784469358,"author":{"id":"3577852034187700","authorId":"3577852034187700","name":"经济观察报","avatar":"https://static.tigerbbs.com/f64ac2aa784ef0f271ddeb45c7dc72bc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577852034187700","authorIdStr":"3577852034187700"},"themes":[],"title":"EEO全球财经周报 | 奥密克戎已散播至美国15个州;日本拟不再允许留学生免税购物;半导体市场规模2022年预计突破6000亿美元","htmlText":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","listText":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","text":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608423292","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603611582,"gmtCreate":1638404849163,"gmtModify":1638404849246,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"[Surprised] ","listText":"[Surprised] ","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603611582","repostId":"1196358645","repostType":4,"repost":{"id":"1196358645","pubTimestamp":1638399984,"share":"https://www.laohu8.com/m/news/1196358645?lang=&edition=full","pubTime":"2021-12-02 07:06","market":"us","language":"en","title":"Wall St turns red as Omicron reaches the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1196358645","media":"StreetInsider","summary":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor ","content":"<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.</p>\n<p>After having advanced as much as 1.9% by late morning, the S&P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.</p>\n<p>Late in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.</p>\n<p>Earlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.</p>\n<p>Wall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.</p>\n<p>\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.</p>\n<p>Wall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.</p>\n<p>On Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]</p>\n<p>\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.</p>\n<p>The Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.</p>\n<p>The Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.</p>\n<p>While all of the 11 major S&P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.</p>\n<p>The sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.</p>\n<p>The CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.</p>\n<p>The economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.</p>\n<p>The World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.</p>\n<p>Lauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.</p>\n<p>However Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"</p>\n<p>U.S. manufacturing activity picked up in November amid strong demand for goods.</p>\n<p>Salesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.</p>\n<p>The S&P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.</p>\n<p>Trading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St turns red as Omicron reaches the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St turns red as Omicron reaches the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 07:06 GMT+8 <a href=https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the ...</p>\n\n<a href=\"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196358645","content_text":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.\nAfter having advanced as much as 1.9% by late morning, the S&P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.\nLate in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.\nEarlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.\nWall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.\n\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.\nWall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.\nOn Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]\n\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.\nThe Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.\nThe Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.\nWhile all of the 11 major S&P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.\nThe sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.\nThe CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.\nThe economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.\nThe World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.\nLauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.\nHowever Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"\nU.S. manufacturing activity picked up in November amid strong demand for goods.\nSalesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.\nThe S&P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.\nTrading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609355157,"gmtCreate":1638242801014,"gmtModify":1638242810818,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"[微笑]","listText":"[微笑]","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609355157","repostId":"2187672306","repostType":2,"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874556134,"gmtCreate":1637804117231,"gmtModify":1637804919617,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"good read","listText":"good read","text":"good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874556134","repostId":"1108125446","repostType":2,"repost":{"id":"1108125446","pubTimestamp":1637802593,"share":"https://www.laohu8.com/m/news/1108125446?lang=&edition=full","pubTime":"2021-11-25 09:09","market":"us","language":"en","title":"Cathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.","url":"https://stock-news.laohu8.com/highlight/detail?id=1108125446","media":"Barrons","summary":"Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries","content":"<p>Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.</p>\n<p>Wood, a widely followed stock picker, founded and runs the asset-management firm ARK Invest. ARK currently offers six actively managed exchange-traded funds, but none have the capability to short stocks––borrowing shares and selling them later in a bet that prices would drop.</p>\n<p>The new portfolio, currently being tested internally, would be able to not only own stocks, but also to short them, Wood told CNBC on Wednesday, She plans to focus her short selling on stocks in big benchmarks that are vulnerable to innovation-driven changes. The CEO characterized the new approach as “ARK on steroids.”</p>\n<p>“We think the benchmarks are where the big risks are longer-term, because they are filling up with value traps––those companies that have done very well historically but are going to be disintermediated and disrupted by the massive amount of innovation that’s taking place,” she said.</p>\n<p>ARK ETFs are known for focusing solely on innovators and industry disrupters like Tesla (ticker: TSLA) and Square (SQ). Some of the top-performing funds in 2020, the ARK ETFs soared wildly during the pandemic, garnering billions of dollars in assets from retail investors.</p>\n<p>This year, though, the ARK funds have been struggling to repeat their spectacular performance. The flagship ARK Innovation ETF (ARKK), which gained 149% in 2020, is down 15% so far in 2021. The ARK Genomic Revolution ETF (ARKG) is down 31% this year after surging 178% in 2020. The S&P 500 index has risen 25% year to date.</p>\n<p>Disruptive innovation––including DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain––is currently priced between $10 trillion and $15 trillion in the global public market, says Wood. She believes that in 10 years, they’ll be worth $200 trillion.</p>\n<p>But this year, investors have favored cheaper cyclical stocks that could benefit from the postpandemic recovery. ARK doubters believe that highflying names in ARK funds’ portfolios are too pricey, especially in an inflationary environment where growth companies’ future cash flows are considered less valuable today.</p>\n<p>An increasing number of bears have been borrowing shares of ARK ETFs and selling them short, hoping to profit from a price drop. There is even an “anti-ARK” ETF––the Tuttle Capital Short Innovation ETF (SARK) launched two weeks ago––that tracks the inverse performance of the ARK Innovation ETF through swaps contracts.</p>\n<p>The ability to short stocks could make ARK funds even more volatile than they are today. But Wood doesn’t think the current inflation––and its negative impact on her stock picks––will last. She has repeatedly said that the economy’s long-term trend is deflation rather than inflation, due to the downward price pressure coming from technology innovation.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 09:09 GMT+8 <a href=https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.\n...</p>\n\n<a href=\"https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","SARK":"Tradr 2X Short Innovation Daily ETF","ARKK":"ARK Innovation ETF"},"source_url":"https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108125446","content_text":"Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.\nWood, a widely followed stock picker, founded and runs the asset-management firm ARK Invest. ARK currently offers six actively managed exchange-traded funds, but none have the capability to short stocks––borrowing shares and selling them later in a bet that prices would drop.\nThe new portfolio, currently being tested internally, would be able to not only own stocks, but also to short them, Wood told CNBC on Wednesday, She plans to focus her short selling on stocks in big benchmarks that are vulnerable to innovation-driven changes. The CEO characterized the new approach as “ARK on steroids.”\n“We think the benchmarks are where the big risks are longer-term, because they are filling up with value traps––those companies that have done very well historically but are going to be disintermediated and disrupted by the massive amount of innovation that’s taking place,” she said.\nARK ETFs are known for focusing solely on innovators and industry disrupters like Tesla (ticker: TSLA) and Square (SQ). Some of the top-performing funds in 2020, the ARK ETFs soared wildly during the pandemic, garnering billions of dollars in assets from retail investors.\nThis year, though, the ARK funds have been struggling to repeat their spectacular performance. The flagship ARK Innovation ETF (ARKK), which gained 149% in 2020, is down 15% so far in 2021. The ARK Genomic Revolution ETF (ARKG) is down 31% this year after surging 178% in 2020. The S&P 500 index has risen 25% year to date.\nDisruptive innovation––including DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain––is currently priced between $10 trillion and $15 trillion in the global public market, says Wood. She believes that in 10 years, they’ll be worth $200 trillion.\nBut this year, investors have favored cheaper cyclical stocks that could benefit from the postpandemic recovery. ARK doubters believe that highflying names in ARK funds’ portfolios are too pricey, especially in an inflationary environment where growth companies’ future cash flows are considered less valuable today.\nAn increasing number of bears have been borrowing shares of ARK ETFs and selling them short, hoping to profit from a price drop. There is even an “anti-ARK” ETF––the Tuttle Capital Short Innovation ETF (SARK) launched two weeks ago––that tracks the inverse performance of the ARK Innovation ETF through swaps contracts.\nThe ability to short stocks could make ARK funds even more volatile than they are today. But Wood doesn’t think the current inflation––and its negative impact on her stock picks––will last. She has repeatedly said that the economy’s long-term trend is deflation rather than inflation, due to the downward price pressure coming from technology innovation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":603611582,"gmtCreate":1638404849163,"gmtModify":1638404849246,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"[Surprised] ","listText":"[Surprised] ","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603611582","repostId":"1196358645","repostType":4,"repost":{"id":"1196358645","pubTimestamp":1638399984,"share":"https://www.laohu8.com/m/news/1196358645?lang=&edition=full","pubTime":"2021-12-02 07:06","market":"us","language":"en","title":"Wall St turns red as Omicron reaches the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1196358645","media":"StreetInsider","summary":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor ","content":"<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.</p>\n<p>After having advanced as much as 1.9% by late morning, the S&P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.</p>\n<p>Late in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.</p>\n<p>Earlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.</p>\n<p>Wall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.</p>\n<p>\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.</p>\n<p>Wall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.</p>\n<p>On Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]</p>\n<p>\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.</p>\n<p>The Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.</p>\n<p>The Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.</p>\n<p>While all of the 11 major S&P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.</p>\n<p>The sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.</p>\n<p>The CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.</p>\n<p>The economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.</p>\n<p>The World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.</p>\n<p>Lauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.</p>\n<p>However Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"</p>\n<p>U.S. manufacturing activity picked up in November amid strong demand for goods.</p>\n<p>Salesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.</p>\n<p>The S&P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.</p>\n<p>Trading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St turns red as Omicron reaches the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St turns red as Omicron reaches the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 07:06 GMT+8 <a href=https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the ...</p>\n\n<a href=\"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196358645","content_text":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.\nAfter having advanced as much as 1.9% by late morning, the S&P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.\nLate in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.\nEarlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.\nWall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.\n\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.\nWall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.\nOn Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]\n\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.\nThe Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.\nThe Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.\nWhile all of the 11 major S&P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.\nThe sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.\nThe CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.\nThe economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.\nThe World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.\nLauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.\nHowever Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"\nU.S. manufacturing activity picked up in November amid strong demand for goods.\nSalesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.\nThe S&P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.\nTrading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606054517,"gmtCreate":1638802922540,"gmtModify":1638802922637,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"Board risk off sentiments now - Expect higher volatility till the end of the year.","listText":"Board risk off sentiments now - Expect higher volatility till the end of the year.","text":"Board risk off sentiments now - Expect higher volatility till the end of the year.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606054517","repostId":"608423292","repostType":1,"repost":{"id":608423292,"gmtCreate":1638781335000,"gmtModify":1638784469358,"author":{"id":"3577852034187700","authorId":"3577852034187700","name":"经济观察报","avatar":"https://static.tigerbbs.com/f64ac2aa784ef0f271ddeb45c7dc72bc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577852034187700","authorIdStr":"3577852034187700"},"themes":[],"title":"EEO全球财经周报 | 奥密克戎已散播至美国15个州;日本拟不再允许留学生免税购物;半导体市场规模2022年预计突破6000亿美元","htmlText":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","listText":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","text":"美国: | 奥密克戎已散播至美国15个州 美国疾病控制和预防中心主任瓦伦斯基(Rochelle Walensky)5日说,截至4日晚上,奥密克戎毒株已在美国约15个州出现,但德尔塔变体仍占该国新冠病例的大多数。虽然一些患者最近曾前往首次发现该毒株的非洲,但也有患者没有任何旅行史,这表明奥密克戎毒株正在美国社区进行传播。白宫首席防疫顾问福奇也说,在美国国内绝对存在(奥密克戎毒株)社区传播。福奇警告,美国有可能进入第五波疫情,疫情的严重性将要视“我们在未来几周及几个月所采取的行动而定”,人们要准备采取任何行动阻止感染率再度回升。(来源:联合早报) | FDA计划快速审核针对奥密克戎的疫苗和药物 据知情人士表示,美国食品药品管理局(FDA)正在为快速审核针对奥密克戎(Omicron)的疫苗和药物奠定基础,前提是它们被证明是有必要的。在今年早些时候制定的评估疫苗和疗法的规则基础上,FDA一直在与制药商碰面,并为迅速评估针对奥密克戎变异株的产品所需的研究和数据制定指导方针。据知情人士称,FDA希望在授权使用奥密克戎疫苗和疗法之前确保它们是安全有效的并且可以准确无误地生产出来,同时,FDA将尽快采取行动进行评估,以赶在该病毒变种让疫苗无效之前形成防护力。(来源:华尔街日报) | 若能源价格下跌 美国或将调整战略石油储备释放计划的时间 美国能源部副部长David Turk 1日表示,如果全球能源价格大幅下跌,拜登政府可能会调整释放战略原油储备计划的时间。Turk在Reuters Next会议的视频采访中表示,如有必要,其他已经同意与美国一起释放战略储备以控制价格的消费国也可以调整释放时机。拜登政府上月宣布,将从美国战略石油储备中释放5,000万桶石油,同时中国、印度、日本、韩国和英国也将释放少量石油,以帮助降低消费者的能源成本。(来源:路透社) |","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608423292","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609355157,"gmtCreate":1638242801014,"gmtModify":1638242810818,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"[微笑]","listText":"[微笑]","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609355157","repostId":"2187672306","repostType":2,"repost":{"id":"2187672306","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638222060,"share":"https://www.laohu8.com/m/news/2187672306?lang=&edition=full","pubTime":"2021-11-30 05:41","market":"us","language":"en","title":"DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2187672306","media":"Dow Jones","summary":"DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors\n\n\n This article","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors\n</p>\n<p>\n This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n Shares of Bristol Myers Squibb Co. <a href=\"https://laohu8.com/S/BMY\">$(BMY)$</a> slipped 3.34% to $54.64 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.32% to 4,655.27 and the Dow Jones Industrial Average rising 0.68% to 35,135.94. This was the stock's third consecutive day of losses. Bristol Myers Squibb Co. closed $15.11 short of its 52-week high ($69.75), which the company reached on August 23rd. \n</p>\n<p>\n The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.35% to $159.75, Merck & Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 5.39% to $74.89, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 2.96% to $52.40. Trading volume (20.6 M) eclipsed its 50-day average volume of 11.5 M. \n</p>\n<p>\n Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2021. \n</p>\n<p>\n -MarketWatch Automation \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n November 29, 2021 16:41 ET (21:41 GMT)\n</p>\n<p>\n Copyright (c) 2021 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-30 05:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors\n</p>\n<p>\n This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n Shares of Bristol Myers Squibb Co. <a href=\"https://laohu8.com/S/BMY\">$(BMY)$</a> slipped 3.34% to $54.64 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.32% to 4,655.27 and the Dow Jones Industrial Average rising 0.68% to 35,135.94. This was the stock's third consecutive day of losses. Bristol Myers Squibb Co. closed $15.11 short of its 52-week high ($69.75), which the company reached on August 23rd. \n</p>\n<p>\n The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.35% to $159.75, Merck & Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 5.39% to $74.89, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 2.96% to $52.40. Trading volume (20.6 M) eclipsed its 50-day average volume of 11.5 M. \n</p>\n<p>\n Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2021. \n</p>\n<p>\n -MarketWatch Automation \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n November 29, 2021 16:41 ET (21:41 GMT)\n</p>\n<p>\n Copyright (c) 2021 Dow Jones & Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4532":"文艺复兴科技持仓","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BMY":"施贵宝"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187672306","content_text":"DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors\n\n\n This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 3.34% to $54.64 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.32% to 4,655.27 and the Dow Jones Industrial Average rising 0.68% to 35,135.94. This was the stock's third consecutive day of losses. Bristol Myers Squibb Co. closed $15.11 short of its 52-week high ($69.75), which the company reached on August 23rd. \n\n\n The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.35% to $159.75, Merck & Co. Inc. $(MRK)$ fell 5.39% to $74.89, and Pfizer Inc. $(PFE)$ fell 2.96% to $52.40. Trading volume (20.6 M) eclipsed its 50-day average volume of 11.5 M. \n\n\n Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2021. \n\n\n -MarketWatch Automation \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n November 29, 2021 16:41 ET (21:41 GMT)\n\n\n Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874556134,"gmtCreate":1637804117231,"gmtModify":1637804919617,"author":{"id":"3578464057789843","authorId":"3578464057789843","name":"SamuChong","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578464057789843","authorIdStr":"3578464057789843"},"themes":[],"htmlText":"good read","listText":"good read","text":"good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874556134","repostId":"1108125446","repostType":2,"repost":{"id":"1108125446","pubTimestamp":1637802593,"share":"https://www.laohu8.com/m/news/1108125446?lang=&edition=full","pubTime":"2021-11-25 09:09","market":"us","language":"en","title":"Cathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.","url":"https://stock-news.laohu8.com/highlight/detail?id=1108125446","media":"Barrons","summary":"Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries","content":"<p>Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.</p>\n<p>Wood, a widely followed stock picker, founded and runs the asset-management firm ARK Invest. ARK currently offers six actively managed exchange-traded funds, but none have the capability to short stocks––borrowing shares and selling them later in a bet that prices would drop.</p>\n<p>The new portfolio, currently being tested internally, would be able to not only own stocks, but also to short them, Wood told CNBC on Wednesday, She plans to focus her short selling on stocks in big benchmarks that are vulnerable to innovation-driven changes. The CEO characterized the new approach as “ARK on steroids.”</p>\n<p>“We think the benchmarks are where the big risks are longer-term, because they are filling up with value traps––those companies that have done very well historically but are going to be disintermediated and disrupted by the massive amount of innovation that’s taking place,” she said.</p>\n<p>ARK ETFs are known for focusing solely on innovators and industry disrupters like Tesla (ticker: TSLA) and Square (SQ). Some of the top-performing funds in 2020, the ARK ETFs soared wildly during the pandemic, garnering billions of dollars in assets from retail investors.</p>\n<p>This year, though, the ARK funds have been struggling to repeat their spectacular performance. The flagship ARK Innovation ETF (ARKK), which gained 149% in 2020, is down 15% so far in 2021. The ARK Genomic Revolution ETF (ARKG) is down 31% this year after surging 178% in 2020. The S&P 500 index has risen 25% year to date.</p>\n<p>Disruptive innovation––including DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain––is currently priced between $10 trillion and $15 trillion in the global public market, says Wood. She believes that in 10 years, they’ll be worth $200 trillion.</p>\n<p>But this year, investors have favored cheaper cyclical stocks that could benefit from the postpandemic recovery. ARK doubters believe that highflying names in ARK funds’ portfolios are too pricey, especially in an inflationary environment where growth companies’ future cash flows are considered less valuable today.</p>\n<p>An increasing number of bears have been borrowing shares of ARK ETFs and selling them short, hoping to profit from a price drop. There is even an “anti-ARK” ETF––the Tuttle Capital Short Innovation ETF (SARK) launched two weeks ago––that tracks the inverse performance of the ARK Innovation ETF through swaps contracts.</p>\n<p>The ability to short stocks could make ARK funds even more volatile than they are today. But Wood doesn’t think the current inflation––and its negative impact on her stock picks––will last. She has repeatedly said that the economy’s long-term trend is deflation rather than inflation, due to the downward price pressure coming from technology innovation.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Is Testing ‘ARK on Steroids.’ She Wants to Bet Against Disruption’s Victims.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 09:09 GMT+8 <a href=https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.\n...</p>\n\n<a href=\"https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","SARK":"Tradr 2X Short Innovation Daily ETF","ARKK":"ARK Innovation ETF"},"source_url":"https://www.barrons.com/articles/cathie-wood-ark-invest-short-selling-51637788917?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108125446","content_text":"Cathie Wood’s investment firm, known for investing in companies that are shaking up their industries, is testing a portfolio that would let her bet against the corporate victims of that disruption.\nWood, a widely followed stock picker, founded and runs the asset-management firm ARK Invest. ARK currently offers six actively managed exchange-traded funds, but none have the capability to short stocks––borrowing shares and selling them later in a bet that prices would drop.\nThe new portfolio, currently being tested internally, would be able to not only own stocks, but also to short them, Wood told CNBC on Wednesday, She plans to focus her short selling on stocks in big benchmarks that are vulnerable to innovation-driven changes. The CEO characterized the new approach as “ARK on steroids.”\n“We think the benchmarks are where the big risks are longer-term, because they are filling up with value traps––those companies that have done very well historically but are going to be disintermediated and disrupted by the massive amount of innovation that’s taking place,” she said.\nARK ETFs are known for focusing solely on innovators and industry disrupters like Tesla (ticker: TSLA) and Square (SQ). Some of the top-performing funds in 2020, the ARK ETFs soared wildly during the pandemic, garnering billions of dollars in assets from retail investors.\nThis year, though, the ARK funds have been struggling to repeat their spectacular performance. The flagship ARK Innovation ETF (ARKK), which gained 149% in 2020, is down 15% so far in 2021. The ARK Genomic Revolution ETF (ARKG) is down 31% this year after surging 178% in 2020. The S&P 500 index has risen 25% year to date.\nDisruptive innovation––including DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain––is currently priced between $10 trillion and $15 trillion in the global public market, says Wood. She believes that in 10 years, they’ll be worth $200 trillion.\nBut this year, investors have favored cheaper cyclical stocks that could benefit from the postpandemic recovery. ARK doubters believe that highflying names in ARK funds’ portfolios are too pricey, especially in an inflationary environment where growth companies’ future cash flows are considered less valuable today.\nAn increasing number of bears have been borrowing shares of ARK ETFs and selling them short, hoping to profit from a price drop. There is even an “anti-ARK” ETF––the Tuttle Capital Short Innovation ETF (SARK) launched two weeks ago––that tracks the inverse performance of the ARK Innovation ETF through swaps contracts.\nThe ability to short stocks could make ARK funds even more volatile than they are today. But Wood doesn’t think the current inflation––and its negative impact on her stock picks––will last. She has repeatedly said that the economy’s long-term trend is deflation rather than inflation, due to the downward price pressure coming from technology innovation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}